Search

everythinglearnresearchcommunity

for

Search:↓

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

Physalis peruviana extract is more effective in treating benign prostatic hyperplasia in rats than finasteride and terazosine.

Human scalp hair follicles have PGE2 and its receptors, which might affect hair growth.

Gestrinone pellets may help reduce pelvic pain in endometriosis safely.

Finding functions for unknown GPCRs is hard but key for making new drugs.

New treatments for hair loss focus on targeting specific causes to improve effectiveness and safety.

Dobutamine does not mimic dopamine at therapeutic doses but may at very high concentrations; microfilaments, not microtubules, are important for wound healing in Xenopus embryos.

Neurosteroids can influence behavior by modulating brain inhibition, with potential for treating psychiatric disorders.

Elagolix did not effectively treat polycystic ovary syndrome.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Different types of androgens bind differently to two receptors, AR1 and AR2, in Atlantic croaker's brain and ovarian tissues, suggesting these receptors may control different androgen actions in fish.

Targeting 5α-reductase type 1 may help manage Tourette-like symptoms.

The assay quickly identifies substances that increase or decrease blood vessel growth.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, which could be a new target for treating hair loss and other skin conditions driven by testosterone.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

PEVIII is a promising treatment for Pseudomonas aeruginosa keratitis.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

Certain substances can decrease or increase exploratory behavior in rodents.

Topical prostaglandin analogues may improve hair density in androgenetic alopecia, but more research is needed.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

SM04554 may increase hair growth as a topical treatment for androgenetic alopecia.

Stress worsens Tourette symptoms by increasing allopregnanolone levels.

PCA hydrogel promotes hair growth by enhancing blood vessel formation and hair follicle stem cell activity.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Amygdalin in Persicae Semen may help treat hair loss by promoting hair growth and regulating key pathways.